Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP003337priorityCriticalpatent/ECSP003337A/en
Publication of ECSP003337ApublicationCriticalpatent/ECSP003337A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invención se refiere a nuevas pirazolalquilamidas de fórmula general (I), (gráfico), se describen también procedimientos para la obtención de pirazolalquilamidas. La etapa clave de la obtención es la alquilación de amidas primarias o la amidación de ácidos carboxílicos como alquilamidas. Las pirazolalquilamidas se utilizan como medicamentos, especialmente como medicamentos para el tratamiento y profilaxis de anemias.The present invention relates to new pyrazolalkylamides of general formula (I), (graph), procedures for obtaining pyrazolalkylamides are also described. The key step in obtaining it is the alkylation of primary amides or the amidation of carboxylic acids such as alkylamides. Pyrazolalkylamides are used as medicines, especially as medicines for the treatment and prophylaxis of anemias.
Compounds, process for the manufacture of such compounds, pharmaceutical compositions comprising them, process for the treatment and / or prophylaxis of diseases and use of the compounds
Compound, pharmaceutical formulation, method for inhibiting a proline / alanine cleaving protease, method for treatment or prophylaxis of disorders, and use of the compound
COMPOUNDS DERIVED FROM LEUCINAMIDE, INHIBITORS OF PROTEASA CISTEINE; PHARMACEUTICAL COMPOSITION; PHARMACEUTICAL COMPOSITION PREPARATION PROCEDURE; AND ITS USE IN THE TREATMENT OF OSTEOPOROSIS, PAGET'S DISEASE, PERIDONTAL, LOST